239 related articles for article (PubMed ID: 26583648)
21. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
22. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
Ramsay DL; Parnes RE; Dubin N
Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
[TBL] [Abstract][Full Text] [Related]
23. Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings.
Wehkamp U; Ardigò M; Papadavid E; Querfeld C; Nikbakht N
Adv Ther; 2022 Sep; 39(9):3979-4002. PubMed ID: 35852707
[TBL] [Abstract][Full Text] [Related]
24. Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.
Querfeld C; Scarisbrick JJ; Assaf C; Guenova E; Bagot M; Ortiz-Romero PL; Quaglino P; Bonizzoni E; Hodak E
Dermatology; 2022; 238(2):347-357. PubMed ID: 34091453
[TBL] [Abstract][Full Text] [Related]
25. Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports.
Lampadaki K; Koumourtzis M; Karagianni F; Marinos L; Papadavid E
Adv Ther; 2021 Jun; 38(6):3455-3464. PubMed ID: 33928511
[TBL] [Abstract][Full Text] [Related]
26. The treatment of mycosis fungoides with ointment-based mechlorethamine.
Price NM; Deneau DG; Hoppe RT
Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous T cell lymphoma: update of treatment.
Zackheim HS
Dermatology; 1999; 199(2):102-5. PubMed ID: 10559573
[TBL] [Abstract][Full Text] [Related]
28. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
Trager MH; Chen C; Husain S; Geskin LJ
J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
[TBL] [Abstract][Full Text] [Related]
29. Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis.
Lindahl LM; Fenger-Gron M; Iversen L
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):163-8. PubMed ID: 22229501
[TBL] [Abstract][Full Text] [Related]
30. Healthcare resource utilization, costs of care, and treatment of mycosis fungoides cutaneous T-cell lymphoma patterns in a large managed care population: a retrospective US claims-based analysis.
Tsang Y; Gu T; Sharma G; Raspa S; Drake B; Tan H
J Dermatolog Treat; 2018 Dec; 29(8):747-753. PubMed ID: 29733229
[TBL] [Abstract][Full Text] [Related]
31. Concomitant mycosis fungoides and vitiligo: how mycosis fungoides may contribute to melanocyte destruction.
Herrmann JL; Syklawer E; Tarrillion M; Duvic M; Hughey LC
Dermatology; 2015; 230(2):143-9. PubMed ID: 25634551
[TBL] [Abstract][Full Text] [Related]
32. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
33. Topical chlormethine gel in the treatment of mycosis fungoides: A single-center real-life experience and systematic review of the literature.
Laghi A; Franceschini C; Mandel VD; Teoli M; Musicco F; Sansone M; La Malfa AM; Ardigò M
Dermatol Ther; 2022 Sep; 35(9):e15683. PubMed ID: 35778940
[TBL] [Abstract][Full Text] [Related]
34. Lack of Systemic Absorption of Topical Mechlorethamine Gel in Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
Querfeld C; Geskin LJ; Kim EJ; Scarisbrick JJ; Quaglino P; Papadavid E; Angello JT; Ortiz-Romero PL
J Invest Dermatol; 2021 Jun; 141(6):1601-1604.e2. PubMed ID: 33347924
[No Abstract] [Full Text] [Related]
35. Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration.
Price NM
Arch Dermatol; 1977 Oct; 113(10):1387-9. PubMed ID: 911166
[TBL] [Abstract][Full Text] [Related]
36. VALCHLOR (Mechlorethamine) 0.02% Gel.
Gupta AK; MacLeod MA; Abramovits W
Skinmed; 2016; 14(2):120-2. PubMed ID: 27319956
[No Abstract] [Full Text] [Related]
37. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
Constantine VS; Fuks ZY; Farber EM
Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
[TBL] [Abstract][Full Text] [Related]
38. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
Hamminga B; Noordijk EM; van Vloten WA
Arch Dermatol; 1982 Mar; 118(3):150-3. PubMed ID: 7065660
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the Treatment Patterns of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: By-time Reanalysis of a Randomized Controlled Phase 2 Study.
Geskin LJ; Kim EJ; Angello JT; Kim YH
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):119-124.e4. PubMed ID: 33358692
[TBL] [Abstract][Full Text] [Related]
40. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases.
Arundell FD; Chan WH
Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
